A systematic review of the medical evidence has determined that drug-eluting stents (DES) outperform bare-metal stents (BMS) for revascularization of chronic total occlusions (CTOs). The consistency and magnitude of treatment effect across both individual trials and the pooled analysis establish DES as the preferred therapy for percutaneous revascularization of CTOs, according to a study in the February issue of Catheterization and Cardiovascular Interventions.

Hologic has received approval from the FDA for its Selenia Dimensions 3D digital breast tomosynthesis system.

Women had a 70 percent decrease in heart failure and 72 percent reduction in death when undergoing cardiac resynchronization therapy with defibrillator (CRT-D) when compared with men, according to sub-analysis of the MADIT-CRT trial published in the Feb. 7 issue of the Journal of the American College of Cardiology.

The Centers for Medicare & Medicaid Services (CMS) has selected five participants in the Medicare Imaging Demonstration, a demonstration project that promotes appropriate utilization of advanced imaging services.

Its been a year since CMIO put a stake in the ground, conducting the first-ever CMIO Compensation Survey. Some 225 chief medical information/informatics officers nationwide offered their insight, while establishing a baseline of compensation data upon which to build subsequent surveys.

Radiologists need to recognize teleradiology as a threat, and except in very limited circumstances, return to the standard modus operandi that includes covering night and weekend call, according to an article published in the February issue of the Journal of the American College of Radiology.

The U.S. Department of Justice has filed a complaint against Boston Scientific and related Guidant entities under the False Claims Act for knowingly selling defective implantable cardioverter-defibrillators (ICDs), the DoJ announced Jan. 27.

A federal judge from Texas has ordered Johnson & Johnson, and its subsidiary Cordis, to pay $482 million to radiologist Bruce Saffran, MD, after the jury found that the company infringed Saffrans patent (No. 5,363,760)Method and Apparatus for Managing Macromolecular Distribution.